| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.96巴西雷亚尔,归母净利润21.30亿巴西雷亚尔,同比去年增长40.07%
|
| 2025-09-02 |
详情>>
股本变动：
变动后总股本106777.90万股
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益1.30巴西雷亚尔,归母净利润14.21亿巴西雷亚尔,同比去年增长63.47%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益0.30巴西雷亚尔,归母净利润3.33亿巴西雷亚尔,同比去年增长-22.86%
|
| 2025-04-23 |
详情>>
业绩披露：
2022年年报每股收益1.65巴西雷亚尔,归母净利润18.01亿巴西雷亚尔,同比去年增长111.75%
|
| 2025-04-23 |
详情>>
业绩披露：
2024年年报每股收益2.14巴西雷亚尔,归母净利润23.63亿巴西雷亚尔,同比去年增长-3.16%
|
| 2025-01-13 |
股东大会：
将于2025-04-16召开股东大会
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.38巴西雷亚尔,归母净利润15.21亿巴西雷亚尔,同比去年增长13.44%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益0.79巴西雷亚尔,归母净利润8.69亿巴西雷亚尔,同比去年增长82.67%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益0.39巴西雷亚尔,归母净利润4.31亿巴西雷亚尔,同比去年增长64.64%
|
| 2024-04-23 |
详情>>
业绩披露：
2023年年报每股收益2.23巴西雷亚尔,归母净利润24.40亿巴西雷亚尔,同比去年增长35.48%
|
| 2024-03-18 |
股东大会：
将于2024-04-17召开股东大会
会议内容 ▼▲
- At the Annual General Shareholders’ Meeting:
1.Analysis and approval of the report and accounts of the Management, as well as the financial statements of the fiscal year ended on December 31st, 2023, together with the report from the Independent Auditors and the opinion from the Fiscal Council.
2.Allocation of net income for the fiscal year ended on December 31st, 2023.
3.Establishment of the Management's global compensation.
4.Election of the members of the Fiscal Council and their respective alternates, given the request for the installation of the Fiscal Council made by a shareholder representing more than 2% of the voting shares issued by the Company, under the terms of the Brazilian Federal Law No. 6,404/76 and CVM Resolution 70/22 (“RCVM 70”).
5.Considering the item above, the establishment of the compensation of the members of the Fiscal Council for the term of office that begins in April 2024.
At the Extraordinary General Shareholders’ Meeting:
1.Amendments to the Company's Bylaws, as detailed in the Management Proposal disclosed to the market on this date, to reflect:(a)Inclusion of activity in the Company’s corporate purpose;(b)Changes of competencies of the Board of Directors;(c)Exclusion of possibilities to replace members of the statutory advisory committees;(d)Change of nomenclature and competencies of the Board of Directors' advisory committees;(e)Simplification of the wording of statutory provisions, as well as clarity and numbering adjustments.
2.Ratification of the change in the number of common shares into which the Company's capital stock is divided, due to the partial exercise of the rights conferred by the subscription warrants issued by the Company as of the merger of shares issued by Imifarma Produtos Farmacêuticos e Cosméticos S.A. by the Company, approved by the Extraordinary General Shareholders’ Meeting held on January 31st, 2014.
3.Approval of the consolidation of the Bylaws, in order to reflect the changes proposed in the items above.
|
| 2024-02-28 |
财报披露：
美东时间 2024-02-28 盘后发布财报
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.22巴西雷亚尔,归母净利润13.41亿巴西雷亚尔,同比去年增长37.06%
|
| 2023-03-20 |
股东大会：
将于2023-04-19召开股东大会
会议内容 ▼▲
- At the Annual General Shareholders’ Meeting:
1.Analysis and approval of the report and accounts of the Management, as well as the financial statements of the fiscal year ended on December 31, 2022, together with the report from the Independent Auditors and the opinion from the Fiscal Council.
2.Allocation of net income for the fiscal year ended on December 31, 2022.
3.Setting of the number of members to be elected to the Board of Directors.
4.Election of the slate that will compose the Board of Directors.
5.Establishment of the Management's global compensation.
6.Election of the members of the Fiscal Council and their respective alternates, given the request for the installation of the Fiscal Council made by a shareholder representing more than 2% of the voting shares issued by the Company, under the terms of the Law No. 6,404/76 and CVM Resolution 70/22 (“RCVM 70”).
7.Considering the item above, the establishment of the compensation of the members of the Fiscal Council for the term of office that begins in April 2023.
At the Extraordinary General Shareholders’ Meeting:
1.Approval of a new stock-based incentive plan.
2.Approval of an amendment to the stock-based incentive plan approved at the Annual and Extraordinary General Shareholders' Meeting held on April 19th, 2017.
3.Approval of the increase in the Company's capital stock, through the capitalization of part of the profit reserves, without the issuance of new shares, with the consequent amendment of Article 5 of the Bylaws currently in force.
4.Ratification of the change in the number of common shares into which the Company's capital stock is divided, due to the partial exercise of the rights conferred by the subscription warrants issued by the Company as of the approval of the merger of shares issued by Imifarma Produtos Farmaceuticos e Cosmeticos S.A. by the Company by the Extraordinary General Shareholders’ Meeting held on January 31st, 2014.
5.Amendments to the Company's Bylaws, as detailed in the Management Proposal disclosed to the market on this date.
6.Approval of the consolidation of the Bylaws, in order to reflect the changes proposed in the items above.
|
| 2022-03-14 |
股东大会：
将于2022-04-13召开股东大会
会议内容 ▼▲
- In Annual General Shareholders’ Meeting:
1.Analysis and approval of the report and accounts of the Management, as well as the financial statements of the fiscal year ended on December 31, 2021, together with the report from the Independent Auditors and the report from the Fiscal Council;
2.Allocation of net income for the fiscal year ended on December 31, 2021;
3.Establishment of the Management's global compensation;
4.Election of the members of the Fiscal Council and respective alternates, given the request for the installation of the Fiscal Council made by a shareholder representing more than 2% (two percent) of the voting shares issued by the Company, under the terms of Law No. 6,404/76 and CVM Instruction 324/00;
5.Considering the item above, the establishment of the compensation of the members of the Fiscal Council for the term of office that begins in April 2022.
In Extraordinary General Shareholders’ Meeting:
1.Change of the number of members that integrate the Board of Directors;
2.Election of member of the Board of Directors;
3.Resolution on the following amendments to the Company’s Bylaws as detailed in the Management Proposal disclosed to the market on this date:(a)change in the percentage of independent members of the Board of Directors;(b)change in the composition of the advisory committees of the Board of Directors;(c)adaptation of the statutory provisions applicable to the Audit and Risks Committee, in order to adapt it to the requirements of CVM Resolution 23/21;(d)reduction of the percentage of net income to be allocated to the payment of mandatory dividends to shareholders, along with the consequent adjustment in the percentage to be allocated to the investment reserve.
4.Ratification on the change in the number of common shares into which the Company's capital stock is divided, due to the partial exercise of the rights conferred by the subscription warrants issued by the Company as of the approval of the merger of shares issued by Imifarma Produtos Farmacêuticos e Cosméticos S.A. by the Company, approved by the Extraordinary General Shareholders’ Meeting held on January 31, 2014;
5.Approval of the consolidation of the Bylaws, in order to reflect the changes proposed in the items above.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-31 |
股东大会：
将于2021-09-30召开股东大会
|
| 2021-05-26 |
股东大会：
将于2021-06-25召开股东大会
会议内容 ▼▲
- 1.Extrafarma’s Price per Share
1.1.Price per Share Amount
1.2.Number of Shares Offered
1.3.Interest ratio between Ultrapar/Extrafarma shares for the exercise of the Preemptive Rights
1.4.Payment Method
1.5.Installments
1.6.Payment Term
1.7.Adjustment
2.Final Price per Share
2.1.Defined Terms
2.1.Preliminary Acquisition Adjusted Price
2.2.Payment of the Preliminary Acquisition Adjusted Price
2.3.Final Acquisition Price
2.4.Payment of the Acquisition Price Final Adjustment
2.5.Application to the Company’s Shareholders
3.Conditions Precedent
|
| 2021-03-16 |
股东大会：
将于2021-04-14召开股东大会
会议内容 ▼▲
- 1.Analysis and approval of the report and accounts of the Management, as well as the financial statements of the fiscal year ended on 12.31.2020, together with the report from the Independent Auditors and the opinion from the Fiscal Council;
2.Allocation of net income for the fiscal year ended on 12.31.2020;
3.Setting of the number of members to be elected to the Board of Directors;
4.Election of the slate that will compose the Board of Directors;
5.Establishment of the Management's global compensation
6.Election of the members of the Fiscal Council and respective alternates, given the request for the installation of the Fiscal Council made by a shareholder representing more than 2% (two percent) of the voting shares issued by the Company, under the terms of Law No. 6,404/76 and CVM Instruction No. 324/00;
7.Considering the item above, the establishment of the compensation of the members of the Fiscal Council for the term of office that begins in April 2021.
8.Ratify the change in the number of common shares into which the Company's capital stock is divided, due to the partial exercise of the rights conferred by the subscription warrants issued by the Company as of the approval of the merger of shares issued by Imifarma Produtos Farmacêuticos e Cosméticos S.A. by the Company, approved by the Extraordinary General Shareholders’ Meeting held on January 31, 2014.
|
| 2020-08-25 |
股东大会：
将于2020-09-22召开股东大会
会议内容 ▼▲
- 1.Change of the number of members that integrate the Board of Directors;
2.Election of member of the Board of Directors.
|
| 2020-03-17 |
股东大会：
将于2020-04-15召开股东大会
会议内容 ▼▲
- Annual General Meeting:
1.Examination and approval of the report and accounts of the Management, as well as the financial statements with respect to the fiscal year ending on December 31, 2019, accompanied by the report of the Independent Auditors and the opinion of the Fiscal Council;
2.Allocation of the net income for the fiscal year ending on December 31, 2019;
3.Establishment of the Management’s aggregate compensation;
4.Election of the members of the Fiscal Council and their respective alternates given the request for the installation of the Fiscal Council by a shareholder representing more than 2% (two percent) of the voting shares issued by the Company, pursuant to Article 161 of Law 6.404/76 and CVM Instruction 324/00;
5.Considering the foregoing item, the establishment of the compensation of the members of the Fiscal Council for the term of office beginning April 2020.
Extraordinary General Meeting:
6.To ratify the alteration of the number of common shares into which the Company’s capital stock is divided due to partial exercise of the subscription warrants issued by the Company as of the approval of the merger of shares issued by Imifarma Produtos Farmacêuticos e Cosméticos S.A., approved by the Extraordinary General Shareholders’ Meeting held on January 31, 2014.
|
| 2020-02-21 |
除权日：
美东时间 2020-02-28 每股派息0.05美元
|
| 2019-08-15 |
除权日：
美东时间 2019-08-23 每股派息0.04美元
|
| 2019-04-11 |
股东大会：
将于2019-04-10召开股东大会
会议内容 ▼▲
- Extraordinary Shareholder’s Meeting:
1.Approved, by the majority of votes, without amendments or qualifications, according to the voting map attached as Annex I of these Minutes, the following amendments to the Bylaws of the Company, pursuant to the Management Proposal of the Company, disclosed to the market on March 11th, 2019, related to: (a) the adaptation of the statutory provisions pursuant to the New Market Regulation, effective since January 02, 2018; (b) the modification of the maximum number of members of the Board of Directors; (c) the modification of the duties of the management bodies, in order to optimize the Company’s decision-making and the corporate governance procedures; (d) the creation of a strategy committee of the Board of Directors and the standardization of the common provisions to all the statutory committees of the Board of Directors; and (e) the simplification of the wording of statutory provisions through the exclusion of content replicated from the legislation and regulations in effect or through adjusting the Bylaws to the legal text, as well as formal adjustments of renumbering and cross references, when applicable. The reffered amendments were included on the Annex II of this resolution.
2.Approved, by the majority of votes, without amendments or qualifications, according to the voting map attached as Annex I of these Minutes, the stock split of the common shares issued by the Company at the ratio of one existing share for two shares of the same class and type, and the consequent amendment of the caput of Article 5 and Article 6 of the Bylaws, in order to reflect the new number of the shares of the capital stock and the new authorized capital stock of the Company.
2.1As a result of the stock split approved, the capital stock of the Company, as indicated on article 5 of its Bylaws, will increase from 556,405,096 (five hundred and fifty six million, four hundred and five thousand and ninety six reais) common shares to 1.112.810.192 (one billion, one hundred and twelve million, eight hundred and ten thousand, one hundred and ninety two) common shares, and the authorized capital, as indicated on article 6 of the Company’s Bylaws, will increase from 800,000,000 (eight hundred million) shares to 1,600,000,000 (one billion and six hundred million) shares. The reffered amendments were included in Annex II of this resolution.
2.2It is hereby rectified that the financial institution providing Ultrapar’s book-entry registar will credit the new shares into the shareholders’ account as of April 24, 2019 and that the depositary agent of the American Depositary Receipts (ADRs) will distribute the new ADRs as of April 26 of 2019.
3.Approved, by the majority of votes, without amendments or qualifications, according to the voting map attached as Annex I of these Minutes, the consolidation of the Bylaws of the Company, in order to reflect the amendments approved on the foregoing itens, pursuant Annex II.
Annual General Shareholder’s Meeting:
4.Approved, by the majority of votes, without amendments or qualifications, according to the voting map attached as Annex I of these Minutes, with the abstention of those legally restricted to vote, the Management Report and annual accounts, the Financial Statements of the Company and its notes, as well as the independent auditor’s report and the Fiscal Council reports, related to the fiscal year ended on December 31, 2018.
5.Approved, by the majority of votes, without amendments or qualifications, according to the voting map attached as Annex I of these Minutes, the destination of net earnings for the fiscal year ended on December 31, 2018, in the amount of R$ 1,150,421,028.65 (one billion, one hundred and fifty million, four hundred and twenty one thousand, twenty-eight Reais and sixty-five cents), as follows:
a)R$ 57,521,051.43 (fifty seven million, five thousand and twenty one thousand, fifty one Reais and fourty three cents) will be allocated to the legal reserve;
b)R$ 408,335,321.76 (four hundred and eight million, three hundred and thirty five thousand, three hundred and twenty one Reais and seventy six cents) will be allocated to the statutory reserve for investments;
c)R$ 684,564,655.46 (six hundred and eighty four million, five hundred and sixty four thousand, six hundred and fifty five Reais and fourty six cents) were allocated to the payment of dividends to shareholders of common shares, of which R$ 304,240,700.96 (three hundred and four million, two hundred and fourty thousand, seven hundred Reais and ninety six cents) corresponding to R$ 0.56 per share, were paid as interim dividends as approved by the Board of Directors on August 01, 2018. The remaining balance of the dividend approved herein, in the amount of R$ 380,323,954.50 (three hundred and eighty million, three hundred and twenty three thousand, nine hundred and fifty four Reais and fifty cents) were paid to shareholders, as of March 13, 2019, according to the Board of Directors meeting held on February 20, 2019.
6.Approved, by the majority of votes, without amendments or qualifications, according to the voting map attached as Annex I of these Minutes, the setting of the Company’s Board of Directors members in 10 (ten) members.
7.Approved, by the majority of votes, without amendments or qualifications, according to the voting map attached as Annex I of these Minutes, the election of the members of the Board of Directors herein qualified, with term of office until the Annual General Shareholders Meeting to be held on 2021, that will examine the documents referred to in Article 133 of the Brazilian Corporate Law, related to the fiscal year ended on December 31, 2020:
8.Approved, by the majority of votes, without amendments or qualifications, according to the voting map attached as Annex I of these Minutes, the maximum global annual limit for the Company’s management compensation in the amount of R$ 72,000,000.00 (seventy-two million Reais), pursuant to the Management Proposal, filed at the Company’s headquarters.
9.Based on the request for installation of the Fiscal Council made by a shareholder representing more than 2% (two percent) of the voting shares issued by the Company and pursuant to the Article 161 of Law 6,404/76 and CVM Instruction nr 324/00, it was approved, by the majority of votes, according to the voting map attached as Annex I of these Minutes, the election of the following members, including the effective and alternate members, with term of office until the Annual General Shareholders’ Meeting to be held in 2020 that will examine the documents referred in the Article 133 of the Brazilian Corporate Law, related to the current fiscal year:
10.Approved, by the majority of votes, without amendments or qualifications, according to the voting map attached as Annex I of these Minutes, the compensation for the members of the Fiscal Council herein elected, provided that the president of the Fiscal Council will be entitled to receive a monthly compensation of R$ 18,500.00 (eighteen thousand and five hundred Reais) and the other effective members will be entitled to receive a monthly compensation of R$ 17,110.00 (seventeen thousand and one hundred and ten Reais).
|
| 2019-04-11 |
详情>>
拆分方案：
每1.0000股拆分成2.0000股
|
| 2019-02-25 |
除权日：
美东时间 2019-03-01 每股派息0.17美元
|
| 2018-08-02 |
除权日：
美东时间 2018-08-10 每股派息0.15美元
|
| 2018-03-12 |
股东大会：
将于2018-04-11召开股东大会
会议内容 ▼▲
- 1.The examination and approval of the Management Report and accounts and financial statements of the fiscal year ended on December 31, 2017, including the report from the Independent Auditors and the opinion from the Fiscal Council;
2.The allocation of net earnings for the fiscal year ended on December 31, 2017;
3.The approval of the annual Management’s compensation;
4.The election of the effective and alternate members of the Fiscal Council based on the request for installation of the Fiscal Council submitted by shareholders representing more than 2% (two percent) of the voting shares issued by the Company, pursuant to article 161 of the Brazilian Corporate Law nr 6.404/76 and CVM Instruction 324/00;
5.In accordance to the item above, approval of the Fiscal Council’s compensation for the period of it terms.
|
| 2018-02-23 |
除权日：
美东时间 2018-03-02 每股派息0.28美元
|
| 2017-08-11 |
除权日：
美东时间 2017-08-17 每股派息0.27美元
|
| 2017-03-21 |
股东大会：
将于2017-04-19召开股东大会
会议内容 ▼▲
- 1.Annual General Shareholders Meeting
1.1.Analysis and approval of the Management Report, Management accounts and financial statements of the fiscal year ended on December 31, 2016, together with the report from the Independent Auditors and the opinion from the Fiscal Council;
1.2.Allocation of net earnings for the fiscal year ended on December 31, 2016;
1.3.Setting of the number of members to be elected to the Board of Directors;
1.4.Election of the members of the Board of Directors;
1.5.Approval of the Management’s compensation;
1.6.Based on the request for installation of the Fiscal Council submitted by shareholders representing more than 2% (two percent) of the voting shares issued by the Company, pursuant to article 161 of the Brazilian Corporate Law and CVM Instruction 324/00:
1.6.a.Election of the effective and alternate members of the Fiscal Council;
1.6.b.Approval of their compensation.
2.Extraordinary Shareholders Meeting
2.1.Proposal for a new stock-based compensation plan;
2.2.Incorporation of the total amount registered in the retained profits reserve, which will result in Ultrapar’s capital increase, without the issuance of new shares;
2.3.Amendment and consolidation of Ultrapar’s Bylaws.
|
| 2017-03-10 |
除权日：
美东时间 2017-03-02 每股派息0.27美元
|
| 2016-12-23 |
股东大会：
将于2017-01-23召开股东大会
|
| 2016-08-29 |
除权日：
美东时间 2016-08-18 每股派息0.25美元
|
| 2016-07-05 |
股东大会：
将于2016-08-03召开股东大会
|
| 2016-03-14 |
股东大会：
将于2016-04-13召开股东大会
会议内容 ▼▲
- 1. Annual General Shareholders Meeting
1.1. Analysis and approval of Management Report, Management accounts and financial statements referring to the fiscal year ended on December 31, 2015, together with the report from the Independent Auditors and the opinion from the Fiscal Council;
1.2. Allocation of net earnings for the fiscal year ended on December 31, 2015;
1.3. Approval of the Management’s compensation;
1.4. Based on the request for installation of the Fiscal Council made by shareholders representing more than 2% (two percent) of the voting shares issued by the Company:
1.4.a. Election of the members of the Fiscal Council;
1.4.b. Approval of its compensation;
2. Extraordinary Shareholders Meeting
2.1. Re-Ratification of the annual overall compensation paid to the Company’s Management in 2012, 2013 and 2014 in compliance with the CVM understanding expressed in the Official Letter 0114/2015/CVM/SEP/GEA-2.
|
| 2016-03-04 |
除权日：
美东时间 2016-02-25 每股派息0.21美元
|
| 2015-08-06 |
除权日：
美东时间 2015-08-13 每股派息0.23美元
|
| 2015-03-16 |
股东大会：
将于2015-04-15召开股东大会
会议内容 ▼▲
- 1.Analysis and approval of the Management’s report, Management’s accounts and financial statements referring to the fiscal year ended on December 31, 2014, together with the report from the Independent Auditors and the opinion from the Fiscal Council;
2. Allocation of net earnings for the fiscal year ended on December 31, 2014;
3. Election of the members of the Board of Directors;
4. Setting of the Management’s compensation;
5. Based on the request for installation of the Fiscal Council made by shareholders representing more than 2% (two percent) of the voting shares issued by the Company:
a. Election of the members of the Fiscal Council;
b. Setting of their compensation.
|
| 2015-02-26 |
除权日：
美东时间 2015-03-05 每股派息0.25美元
|
| 2014-08-07 |
除权日：
美东时间 2014-08-14 每股派息0.31美元
|
| 2014-02-21 |
除权日：
美东时间 2014-02-27 每股派息0.30美元
|
| 2013-08-02 |
除权日：
美东时间 2013-08-08 每股派息0.29美元
|
| 2013-02-21 |
除权日：
美东时间 2013-02-28 每股派息0.33美元
|
| 2012-08-02 |
除权日：
美东时间 2012-08-09 每股派息0.25美元
|
| 2012-02-16 |
除权日：
美东时间 2012-02-23 每股派息0.30美元
|
| 2011-08-11 |
除权日：
美东时间 2011-08-18 每股派息0.29美元
|